Drug profile · INN
sotagliflozin
ZYNQUISTA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sotagliflozin (ZYNQUISTA) is an FDA-listed pharmaceutical active ingredient. Associated with LEXICON PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sotagliflozin
Brand ZYNQUISTA
Route ORAL
Formulation TABLET
ATC code A10
Originator LEXICON PHARMACEUTICALS, INC.
Frequently asked questions
What is sotagliflozin?
sotagliflozin (ZYNQUISTA) is an FDA-listed pharmaceutical active ingredient. Associated with LEXICON PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sotagliflozin?
ZYNQUISTA is a marketed brand name for sotagliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sotagliflozin?
sotagliflozin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.